Could a cheap diabetes pill slow down CLL progression?
NCT ID NCT01750567
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This study tested whether metformin, a common and inexpensive diabetes medication, could help control chronic lymphocytic leukemia (CLL) in 37 patients whose disease had returned after prior treatment or who had a specific genetic change (11q deletion). Researchers monitored how long it took for the leukemia to worsen while patients took metformin. The goal was to see if this well-tolerated drug could delay the need for stronger treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.